Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL1706 + Lenvatinib +/- Cryoablation in Advanced Biliary Tract Cancer
NCT07829874Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of QL1706 in biliary tract cancer (BTC), sponsored by Fudan University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
QL1706
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT07829874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07829874.